Skip to content
MMyGLP Reviews

Fifty 410 Tirzepatide Review 2026

The cheapest compounded tirzepatide figure we have verified anywhere — on a two-band price where nobody tells you where the bands divide.

Updated 2026-09-18 · 4 min read · Prices verified from Fifty 410's own site

Editorial still life representing Fifty 410's compounded Tirzepatide offering

The verdict

$133 a month is the lowest compounded tirzepatide price in this entire dataset, below CoreAge Rx's $129 flat rate and less than a third of Coby Health's maintenance figure. It is also the starter protocol, with a separate High Dose plan at $183 — a 38% step whose boundary Fifty 410 never defines. That single missing detail decides whether this is the cheapest option on the site or a mid-table one. The payment flexibility is genuinely the widest we have seen, and the free no-card intake is a real courtesy.

Advertised price
$133/mo
What you actually pay
$133/mo starter, $183/mo high dose
Transparency3/5
Value4/5
Clinical depth2/5

Best for

Cost-focused buyers on a three-month commitment who establish their dose band before paying.

Skip it if

You need month-to-month billing, ongoing clinical support, or a named pharmacy.

Fifty 410 publishes the lowest compounded tirzepatide price we have found, and then publishes the reason to read it carefully directly beneath it.

Two plans, both three months. The starter dosing protocol is $399 total, or $133 a month. The advanced dosing protocol is $549 total, or $183 a month. Both include the provider consultation and free shipping.

What is missing is the boundary. Neither plan says which doses it covers, so there is no way to tell from the page whether 5 mg is starter or advanced — and that is precisely the question that determines what you pay.

Where it sits if the answer is favourable

At $133 it beats everything: CoreAge Rx at $129 on a 12-month plan, Ondra Health at $142 prepaid annually, Mochi at $169 combined. At $183 it sits between Fridays at $198 and Mochi, which is still good. Either way the pricing is competitive — the uncertainty is about which one applies to you.

Payment flexibility, and a caution about it

Afterpay, Affirm, FSA and HSA are all accepted, which is the widest payment range in this dataset. The intake is free, requires no credit card, and you pay only if a provider approves treatment.

What the platform is, and is not

Fifty 410 states plainly that it is a telehealth platform and does not compound, manufacture or distribute medications, which are prepared by independent FDA-registered 503A pharmacies using FDA-approved active pharmaceutical ingredients. It publishes the compounded-medication disclaimer prominently rather than burying it.

Not published: the pharmacies by name, eligibility criteria, lab requirements, cancellation terms, or any description of ongoing clinical support between refills. The brand voice is also pitched at a notably young audience, which sits awkwardly against a prescription-only injectable.

Where a dose sits on the studied ladder

Move the slider to see whether a dose is one the weight-loss trials actually used. Doses below the studied range may still suit you — they simply have no trial result attached.

MicrodoseTrial maintenance

Standard titration step

Standard schedule: Weeks 1–4

The standard starting dose. Intended to build tolerance, not to produce weight loss.

In the trial programme behind Wegovy, adults reached a 2.4 mg weekly maintenance dose and lost an average of about 15% of body weight over 68 weeks.

Titration schedules are the standard ones for the approved products and are shown for orientation, not as a dosing instruction. Compounded products are not FDA-approved and your prescriber sets your schedule. Never change a dose on the basis of a web page.

What compounded tirzepatide actually is

Tirzepatide is the active ingredient in Mounjaro and Zepbound, both FDA-approved products from Eli Lilly. Unlike semaglutide, it acts on two receptors — GLP-1 and GIP — which is the basis for the larger average weight reductions seen in its trials. A compounded version is prepared by a pharmacy and is not FDA-approved or FDA-evaluated.

Compounded tirzepatide is consistently more expensive than compounded semaglutide, typically by $50 to $100 a month. That gap is real and reflects the raw material, so a provider pricing them identically is worth a question rather than a celebration.

Dosing usually starts at 2.5 mg weekly and escalates in 2.5 mg steps. As with semaglutide, dose-flat pricing is worth substantially more than a low starting price, because the starting dose is not the dose most people end up on.

Side effects mirror semaglutide's — predominantly gastrointestinal, worst after dose increases — though some patients report tirzepatide is better tolerated at equivalent efficacy. That is an individual matter and not something a telehealth intake form can predict for you.

Before you buy from anyone

  1. Get the total monthly cost in writing — medication plus any membership, not the headline figure.
  2. Ask whether the price changes as your dose increases. This is where most of the money is lost.
  3. Ask which pharmacy compounds it, and whether it is a 503A or 503B facility.
  4. Confirm what happens if you stop after one month, and whether there is an auto-rebill.
  5. Ask whether a refund is available if a provider declines to prescribe.
  6. Tell the prescriber every medication and supplement you take, including anything bought online.

Frequently asked questions

How much is Fifty 410 tirzepatide?
$133 a month on the starter protocol ($399 for three months) or $183 a month on the high-dose protocol ($549 for three months), both including consultation and free shipping.
Which doses does the $133 plan cover?
Not published. Fifty 410 describes it as the starter dosing protocol without stating which doses fall inside it — ask before buying, since the high-dose plan is 38% more.
Do I need a credit card to start?
No. The intake is free with no card required, and you pay only if a provider approves treatment.
Can I pay monthly?
Both published plans are three-month commitments, though Afterpay and Affirm allow you to spread the payment. No month-to-month plan is published.

Other tirzepatide providers

How we make money. CoreAge Rx is a paid partner and we earn a commission when you use these links. That pays for this site. It does not change what we publish — every figure on this page comes from CoreAge Rx's own site and is dated, and the ranking criteria are published above the list.

Medical disclaimer

This review is editorial research about a commercial service. It is not medical advice, and it is not a recommendation to start, stop or change any treatment. GLP-1 medications are prescription drugs with real contraindications and side effects. Decisions about whether they are appropriate for you belong with a qualified clinician who knows your medical history. Prices and terms in this category change frequently — we publish the date each review was verified and link every source, but you should confirm current details with the provider before purchasing.